600,000 implants per year – PIP output target in 2008
This article was originally published in Clinica
Poly Implant Prothèse (PIP), the now defunct manufacturer of fraudulent silicone breast implants, was producing some 160,000 implants per year in early 2007, and was set to increase production to 600,000 units by the end of 2008, Clinica has learned.
You may also be interested in...
Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.